Skip to main content

Table 1 Demographic and clinical characteristics in patients at baseline in overall cohort and in groups A and B

From: Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up study

  Overall (n 564) Group A (n 169) Group B (n 395) p*
Gender (% m/% f) 44.9/55.1 43.5/56.5 45.1/54.9 0.22
Age (years) 64.7 ± 8.8 64.4 ± 8.4 65.2 ± 9.2 0.21
Duration of diabetes (years) 9.0 ± 4.1 9.2 ± 4.5 8.9 ± 4.0 0.19
Smoker (%) 25.7 26.4 25.2 0.18
BMI (kg/m2) 29.3 ± 4.6 29.6 ± 4.4 29.2. ± 4.7 0.32
HbA1c (%) 7.4 ± 1.3 7.4 ± 1.4 7.5 ± 1.0 0.26
SBP (mmHg) 135.9 ± 13.2 134.6 ± 15.6 136. ± 16.1 0.21
DBP (mmHg) 78.2 ± 7.3 77.5 ± 6.2 79.9 ± 7.0 0.27
Tot. cholesterol (mg/dl) 196 ± 41.2 198.4 ± 43.6 195.4 ± 40.5 0.19
HDL-C (mg/dl) 48.8 ± 11.9 48.9 ± 12,4 48.4 ± 11.7 0.25
LDL-C (mg/dl) 118.7 ± 31.3 119.5 ± 32.5 117.6 ± 30.9 0.16
Triglycerides (mg/dl) 149.3 ± 80.8 146.9 ± 83.4 150.1 ± 81.7 0.17
UAlb (mg/24 h) 143.1 ± 136.3 139.5 ± 140.4 144.4 ± 131.5 0.12
GFR (mL/min/1.73 m2) 66.4 ± 24.3 66.1 ± 28.1 67.2 ± 25.2 0.22
Anti-hypertensive drugs (%) 84.5 % 83.5 85.3 0.19
OHA (%) 67.7 66.5 68.3 0.20
Insulin (%) 29.4 30.1 28.8 0.18
Statins (%) 29.9 100 0  
Aspirin and/or other antiplatelet drug (%) 42.8 43.1 42.5 0.24
  1. Values are mean ± SD, or percent
  2. GFR estimated glomerular filtration rate using MDRD calculator, HDL high density lipoprotein, LDL low-density lipoprotein, UAlb urinary albumin excretion, OHA oral hypoglycaemic agents
  3. * (p group A vs group B)